“Novel hormonal agents for metastatic Castration-Resistant Prostate Cancer: comparing outcomes. A single-center retrospective study”, Arch Ital Urol Androl, vol. 93, no. 4, pp. 393–398, Dec. 2021, doi: 10.4081/aiua.2021.4.393.